3 Factor Indexing’s Organon & Co OGN Stock Holding History

3 Factor Indexing’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$136	Hold	10	–	–	﹤0.01%	357
2026 Q1	$60	Buy	+10	New	+$75	﹤0.01%	448

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

3 Factor Indexing's OGN Position: Q2 2026 in Review

3 Factor Indexing held its Organon & Co (OGN) position steady in Q2 2026 at 10 shares worth $136. The position accounts for ﹤0.01% of the portfolio, ranked #357.

3 Factor Indexing first reported a position in OGN in Q1 2026 and has held it in 2 quarters since. 594 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

3 Factor Indexing held 10 shares of Organon & Co worth $136 as of Q2 2026.
3 Factor Indexing left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of 3 Factor Indexing's portfolio in Q2 2026, its #357 holding.
3 Factor Indexing first reported a position in Organon & Co in Q1 2026 and has held it in 2 quarters since.
594 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.